Status:
COMPLETED
Children Vaccination From 11 to 14 Years Old
Lead Sponsor:
Centre Hospitalier Eure-Seine
Conditions:
Vaccination Refusal
Opinions
Eligibility:
All Genders
18+ years
Brief Summary
The human papilloma virus infection is the most frequent sexually transmitted infection around the world. In the vast majority of cases, these are inapparent infections that disappear spontaneously. I...
Detailed Description
This qualitative study evaluates parents' opinion regarding the vaccination and the HPV. Parent's eligible to participate in this study are those with boys between 11 and 14 years old. The anti-HPV v...
Eligibility Criteria
Inclusion
- parents having boys between 11 and 14 years old, followed-up by a general practitioner that participate in the study
- signed inform consent form
Exclusion
- language barrier that could prevent the understanding or formulation of opinions during the interview
Key Trial Info
Start Date :
May 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 11 2022
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT04871243
Start Date
May 1 2021
End Date
February 11 2022
Last Update
April 22 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CH Eure-Seine
Évreux, France, 27015